Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985823%3A_____%2F17%3A00487981" target="_blank" >RIV/67985823:_____/17:00487981 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1007/978-3-319-63245-2_14" target="_blank" >http://dx.doi.org/10.1007/978-3-319-63245-2_14</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/978-3-319-63245-2_14" target="_blank" >10.1007/978-3-319-63245-2_14</a>
Alternative languages
Result language
angličtina
Original language name
Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension
Original language description
Pulmonary hypertension is a complex disease of the pulmonary vasculature, which in severe cases terminates in right heart failure. Complex remodeling of pulmonary arteries comprises the central issue of its pathology. This includes extensive proliferation, apoptotic resistance and inflammation. As such, the molecular and cellular features of pulmonary hypertension resemble hallmark characteristics of cancer cell behavior. The vascular remodeling derives from significant metabolic changes in resident cells, which we describe in detail. It affects not only cells of pulmonary artery wall, but also its immediate microenvironment involving cells of immune system (i.e., macrophages). Thus aberrant metabolism constitutes principle component of the cancer-like theory of pulmonary hypertension. The metabolic changes in pulmonary artery cells resemble the cancer associated Warburg effect, involving incomplete glucose oxidation through aerobic glycolysis with depressed mitochondrial catabolism enabling the fueling of anabolic reactions with amino acids, nucleotides and lipids to sustain proliferation. Macrophages also undergo overlapping but distinct metabolic reprogramming inducing specific activation or polarization states that enable their participation in the vascular remodeling process. Such metabolic synergy drives chronic inflammation further contributing to remodeling. Enhanced glycolytic flux together with suppressed mitochondrial bioenergetics promotes the accumulation of reducing equivalents, NAD(P)H. We discuss the enzymes and reactions involved. The reducing equivalents modulate the regulation of proteins using NAD(P)H as the transcriptional co-repressor C-terminal binding protein 1 cofactor and significantly impact redox status (through GSH, NAD(P)H oxidases, etc.), which together act to control the phenotype of the cells of pulmonary arteries. The altered mitochondrial metabolism changes its redox poise, which together with enhanced NAD(P)H oxidase activity and reduced enzymatic antioxidant activity promotes a pro-oxidative cellular status. Herein we discuss all described metabolic changes along with resultant alterations in redox status, which result in excessive proliferation, apoptotic resistance, and inflammation, further leading to pulmonary arterial wall remodeling and thus establishing pulmonary artery hypertension pathology.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
—
OECD FORD branch
30203 - Respiratory systems
Result continuities
Project
<a href="/en/project/LH15071" target="_blank" >LH15071: The role of mitochondrial energy metabolism and redox regulations in pulmonary hypertension</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Pulmonary Vasculature Redox Signaling in Health and Disease
ISBN
978-3-319-63244-5
Number of pages of the result
20
Pages from-to
241-260
Number of pages of the book
422
Publisher name
Springer International Publishing
Place of publication
Cham
UT code for WoS chapter
—